Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cytoplasmic membrane is a phospholipid bilayer that serves as the primary barrier and metabolic hub for bacterial cells. In many bacteria, particularly Gram-positive species, this membrane is heavily enriched with phosphatidylglycerol (PG), an anionic phospholipid that imparts a significant negative surface charge [1.1.5, 1.4.2]. This negative charge is a key physiological feature that allows for the selective targeting of bacteria by cationic antimicrobial peptides and lipopeptide antibiotics like daptomycin [1.1.4, 1.2.4]. Daptomycin specifically interacts with PG in a calcium-dependent manner, leading to its insertion into the membrane, oligomerization, and subsequent membrane depolarization [1.3.1, 1.3.4]. This disruption of the membrane potential and the resulting leakage of intracellular ions, such as potassium, ultimately leads to rapid bacterial cell death [1.3.3]. Beyond its role in drug interaction, the PG-enriched membrane is vital for maintaining the proton motive force required for ATP synthesis and for anchoring proteins involved in cell wall synthesis and division [1.4.3, 1.4.4]. Bacteria can develop resistance to membrane-targeting drugs by modifying PG into lysyl-phosphatidylglycerol, which reduces the net negative charge and decreases drug affinity [1.2.3, 1.2.5]. Consequently, the composition and integrity of the bacterial cytoplasmic membrane are central to both bacterial survival and the efficacy of several classes of life-saving antibiotics [1.1.1, 1.1.3].
Antibacterial agents target the anionic phosphatidylglycerol headgroups, often requiring calcium ions for binding, which facilitates insertion into the lipid bilayer, oligomerization, and subsequent membrane depolarization or pore formation [1.1.4, 1.3.1, 1.3.4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoplasmic membrane (phosphatidylglycerol-enriched).